Sign in
PULM Stock Price, Chart, Stats & News
Pulmatrix, Inc.
Save
Pulmatrix, Inc. (PULM) does not currently pay a dividend.
4.97M
Market cap
–
Current P/E
–
Forward P/E
PULM chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -124.72% |
ROE | -96.97% |
D/E | – |
Interest coverage ratio | – |
PULM valuation
P/E | – |
P/S | – |
P/B | 1.30x |
P/CF | -0.91x |
P/FCF | -0.91x |
P/OCF | -0.91x |
PEG | -0.06x |
EV multiple | -1.76x |
About
Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology.
Similar securities
Based on sector and market capitalization
Report issue